Trial intelligence / Profile preview

PharmaNAC in cystic fibrosis

NCT00809094Phase 2Completed

Sponsor
Stanford University
Start
Nov 2008
Primary completion
Feb 2011
Countries
1
01

Overview

A Phase 2 trial of nacystelyn in cystic fibrosis (CF), sponsored by Stanford University. Started Nov 2008; status: completed.

02

Drugs

nacystelyn
03

Conditions

cystic fibrosis (CF)

Beyond the preview

Go deeper on NCT00809094.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00809094.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call